In this previous study, HbA1c decreased more, less time was spent in hypoglycemia, and insulin pump was used more frequently when real-time data were available to the subjects compared with those during blinded CGM in patients with type 1 diabetes (T1DM) using insulin pump therapy. This evidence concerns the gene INS and Hypoglycemia.